Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.52
+0.58 (8.36%)
At close: Apr 28, 2026, 4:00 PM EDT
7.52
0.00 (0.00%)
Pre-market: Apr 29, 2026, 6:50 AM EDT

Wave Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-183.59-204.38-97.01-57.51-161.82-122.25
Upgrade
Depreciation & Amortization
8.998.858.669.2110.119.84
Upgrade
Loss (Gain) From Sale of Assets
----0.01-
Upgrade
Stock-Based Compensation
29.0824.9713.149.817.1916.41
Upgrade
Change in Accounts Receivable
-0.1519.66-21.09-30
Upgrade
Change in Accounts Payable
4.78-0.563.42-3.769.35-6.57
Upgrade
Change in Unearned Revenue
-38.9-19.83-93.5954.33-3.25-18.46
Upgrade
Change in Other Net Operating Assets
-4.373.31-5.32-10.40.622.04
Upgrade
Operating Cash Flow
-184.01-187.49-151.03-19.43-127.78-88.99
Upgrade
Capital Expenditures
-0.99-0.72-0.94-1.12-1.36-0.56
Upgrade
Sale of Property, Plant & Equipment
----0.11-
Upgrade
Investing Cash Flow
-0.99-0.72-0.94-1.12-1.26-0.56
Upgrade
Issuance of Common Stock
439.67441.3239.81132.5352.9255.83
Upgrade
Other Financing Activities
46.9446.9414.08-14.27-
Upgrade
Financing Cash Flow
486.61488.24253.89132.5367.1955.83
Upgrade
Foreign Exchange Rate Adjustments
-0.050.01-0.14-0.1-0.21-0.21
Upgrade
Net Cash Flow
301.56300.04101.79111.89-62.06-33.93
Upgrade
Free Cash Flow
-185-188.21-151.96-20.55-129.14-89.55
Upgrade
Free Cash Flow Margin
-257.66%-440.50%-140.31%-18.13%-3539.11%-218.61%
Upgrade
Free Cash Flow Per Share
-1.04-1.12-1.10-0.19-1.64-1.73
Upgrade
Levered Free Cash Flow
-129.83-112.55-107.8464.11-67.01-78.24
Upgrade
Unlevered Free Cash Flow
-129.83-112.55-107.8464.11-67.01-78.24
Upgrade
Change in Working Capital
-38.5-16.94-75.8219.086.727.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.